sildenafil zentiva 20mg film-coated tablets
zentiva k.s. u kabelovny 130, dolní mecholupy, 102 37 praha 10, czech republic - sildenafil citrate - film-coated tablet - sildenafil citrate 20 mg - urologicals
etoricoxib zentiva 30 mg film-coated tablets
zentiva k.s. u kabelovny 130, dolní mecholupy, 102 37 praha 10, czech republic - etoricoxib - film-coated tablet - etoricoxib 30 mg - antiinflammatory and antirheumatic products
etoricoxib zentiva 60 mg film-coated tablets
zentiva k.s. u kabelovny 130, dolní mecholupy, 102 37 praha 10, czech republic - etoricoxib - film-coated tablet - etoricoxib 60 mg - antiinflammatory and antirheumatic products
etoricoxib zentiva 90 mg film-coated tablets
zentiva k.s. u kabelovny 130, dolní mecholupy, 102 37 praha 10, czech republic - etoricoxib - film-coated tablet - etoricoxib 90 mg - antiinflammatory and antirheumatic products
etoricoxib zentiva 120 mg film-coated tablets
zentiva k.s. u kabelovny 130, dolní mecholupy, 102 37 praha 10, czech republic - etoricoxib - film-coated tablet - etoricoxib 120 mg - antiinflammatory and antirheumatic products
atorvastatina zentiva italia tablet, film coated 10mg
zentiva k.s. u kabelovny 130, dolní mecholupy, 102 37 praha 10, czech republic - atorvastatin - film-coated tablet - atorvastatin 10 mg - lipid modifying agents
atorvastatina zentiva italia tablet, film coated 20mg
zentiva k.s. u kabelovny 130, dolní mecholupy, 102 37 praha 10, czech republic - atorvastatin - film-coated tablet - atorvastatin 20 mg - lipid modifying agents
atorvastatina zentiva italia tablet, film coated 40mg
zentiva k.s. u kabelovny 130, dolní mecholupy, 102 37 praha 10, czech republic - atorvastatin - film-coated tablet - atorvastatin 40 mg - lipid modifying agents
atorvastatina zentiva italia tablet, film coated 80mg
zentiva k.s. u kabelovny 130, dolní mecholupy, 102 37 praha 10, czech republic - atorvastatin - film-coated tablet - atorvastatin 80 mg - lipid modifying agents
grasustek
juta pharma gmbh - pegfilgrastim - neutropenia - immunostimulants, - reduction in the duration of neutropenia and the incidence of febrile neutropenia in adult patients treated with cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes).